ImmunityBio, Inc. financial data

Symbol
IBRX on Nasdaq
Location
San Diego, CA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 23 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 440% % 30%
Quick Ratio 10% %
Debt-to-equity -179% % -11%
Return On Equity 64% % 2%
Return On Assets -81% % 22%
Operating Margin -316% % 94%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1,028,111,456 shares 20%
Common Stock, Shares, Outstanding 1,011,800,008 shares 19%
Entity Public Float $690,200,000 USD -30%
Common Stock, Value, Issued $101,000 USD 19%
Weighted Average Number of Shares Outstanding, Basic 919,863,000 shares 32%
Weighted Average Number of Shares Outstanding, Diluted 919,863,000 shares 31%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $82,555,000 USD 1026%
Revenue from Contract with Customer, Excluding Assessed Tax $113,288,000 USD 668%
Research and Development Expense $190,144,000 USD -18%
Costs and Expenses $369,315,000 USD 2.9%
Operating Income (Loss) $256,027,000 USD 26%
Nonoperating Income (Expense) $95,580,000 USD -38%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $351,607,000 USD 15%
Income Tax Expense (Benefit) $135,000 USD
Net Income (Loss) Attributable to Parent $351,398,000 USD 15%
Earnings Per Share, Basic -0.38 USD/shares 36%
Earnings Per Share, Diluted -0.38 USD/shares 39%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $88,334,000 USD -38%
Marketable Securities, Current $154,484,000 USD 2321%
Accounts Receivable, after Allowance for Credit Loss, Current $42,571,000 USD 1704%
Inventory, Net $910,000 USD -89%
Other Assets, Current $2,135,000 USD 64%
Assets, Current $314,875,000 USD 71%
Property, Plant and Equipment, Net $114,264,000 USD -17%
Operating Lease, Right-of-Use Asset $33,010,000 USD -1.1%
Intangible Assets, Net (Excluding Goodwill) $16,058,000 USD -15%
Goodwill $910,000 USD 0%
Other Assets, Noncurrent $4,827,000 USD 68%
Assets $501,898,000 USD 31%
Accrued Liabilities, Current $46,838,000 USD 15%
Liabilities, Current $61,754,000 USD 12%
Operating Lease, Liability, Noncurrent $33,447,000 USD -4%
Other Liabilities, Noncurrent $424,000 USD 33%
Liabilities $1,001,472,000 USD 15%
Accumulated Other Comprehensive Income (Loss), Net of Tax $28,956,000 USD 2317%
Retained Earnings (Accumulated Deficit) $3,726,646,000 USD -10%
Stockholders' Equity Attributable to Parent $500,469,000 USD -2.3%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $499,574,000 USD -2.3%
Liabilities and Equity $501,898,000 USD 31%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $85,905,000 USD 20%
Net Cash Provided by (Used in) Financing Activities $982,000 USD -110%
Net Cash Provided by (Used in) Investing Activities $4,129,000 USD
Common Stock, Shares Authorized 1,650,000,000 shares 22%
Common Stock, Shares, Issued 1,011,800,008 shares 19%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $82,768,000 USD 37%
Interest Paid, Excluding Capitalized Interest, Operating Activities $15,593,000 USD -35%
Deferred Tax Assets, Valuation Allowance $855,845,000 USD 10%
Deferred Tax Assets, Gross $872,193,000 USD 9.7%
Operating Lease, Liability $40,982,000 USD -3.1%
Depreciation $13,400,000 USD -14%
Payments to Acquire Property, Plant, and Equipment $1,121,000 USD -11%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $323,640,000 USD 22%
Lessee, Operating Lease, Liability, to be Paid $51,838,000 USD -6.8%
Property, Plant and Equipment, Gross $226,749,000 USD -4.2%
Operating Lease, Liability, Current $7,535,000 USD 0.92%
Lessee, Operating Lease, Liability, to be Paid, Year Two $10,749,000 USD 10%
Lessee, Operating Lease, Liability, to be Paid, Year One $11,400,000 USD -1.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.111 pure 12%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $10,856,000 USD -18%
Lessee, Operating Lease, Liability, to be Paid, Year Three $11,052,000 USD 23%
Deferred Tax Assets, Operating Loss Carryforwards $567,406,000 USD 19%
Preferred Stock, Shares Authorized 20,000,000 shares 0%
Unrecognized Tax Benefits $20,336,000 USD -41%
Lessee, Operating Lease, Liability, to be Paid, Year Four $9,915,000 USD 7.2%
Operating Lease, Payments $2,925,000 USD 23%
Amortization of Intangible Assets $2,000,000 USD 0%
Depreciation, Depletion and Amortization $3,829,000 USD -16%
Share-based Payment Arrangement, Expense $36,809,000 USD 6.9%
Interest Expense $60,886,000 USD -47%
Preferred Stock, Par or Stated Value Per Share 0.0001 USD/shares